EC Number   |
Inhibitors |
Structure |
|---|
   7.4.2.5 | 2,2'-(alpha,alpha'-xylene)bis(sulfanediyl)bis-(6-(4-bromophenyl)-5-cyano-4-oxopyrimidine) |
- |
   |
| 7.4.2.5 | 2,2'-(alpha,alpha'-xylene)bis(sulfanediyl)bis-(6-(biphenyl-4-yl)-5-cyano-4-oxopyrimidine) |
compound does not show antimicrobial activity |
|
| 7.4.2.5 | 2-((4-azidobenzyl)thio)-4-(4-(benzyloxy)phenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile |
good antimicrobial inhibition with MIC of 12.5 microM |
|
| 7.4.2.5 | 2-((4-azidobenzyl)thio)-6-oxo-4-(4-phenoxyphenyl)-1,6-dihydropyrimidine-5-carbonitrile |
good antimicrobial inhibition with MIC of 18.2 microM |
|
| 7.4.2.5 | 2-(benzylsulfanyl)-4-(biphenyl-4-yl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile |
exhibits most potent inhibition effects against strain NR698 with increased outer membrane permeability |
|
| 7.4.2.5 | 3-biphenyl-L-alanyl-L-arginine methyl ester |
peptide derived from lactoferricin, at 1 mM, 10% inhibition of glycylsarcosine-induced current |
|
| 7.4.2.5 | 4-(gamma-aminobutanoyl)-Lys |
- |
|
| 7.4.2.5 | acetyl-Lys |
- |
|
| 7.4.2.5 | alafosfalin |
- |
|
| 7.4.2.5 | anserine |
inhibits uptake of glycylsarcosine |
|
